NHS gets 12 years to roll out new weight-loss drug
We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new generation of weight-loss medicatio
'King Kong' weight loss drug to be given to less than 10% of eligible people in first rollout
Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other vital NHS services".
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to only a small proportion of the patients who could benefit from it.
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible, and alongside a specialized diet.
Eli Lilly Touts Upbeat Weight-Loss Drug Results
Eli Lilly (LLY) stock is rising after the company said its weight-loss drug achieved better results than Wegovy
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout
The “difficult decision” was made “in order to protect other vital NHS services”, the National Institute for Health and Care ...
FiercePharma4h
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
Mounjaro Lawsuits (2024 Update)
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Britain drug-cost watchdog says it will recommend Lilly obesity drug
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...
Life & Style Weekly7h
Comedian Jim Gaffigan’s Weight Loss Transformation Over the Years After Shedding 50 Pounds
Jim Gaffigan revealed he lost 50 pounds via a weight loss drug after struggling for years with his weight. Photos show the ...
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
The Mirror1d
NHS to prescribe ‘King Kong' weight loss jab Mounjaro to the most dangerously obese
However the NHS spending watchdog has announced Mounjaro will only be given to 220,000 people in England during the first three years - despite 3.4 million people being eligible for it. Trials have ...
'Long Starm of the law' and France 'in turmoil'
The paper says France is in "turmoil" and the crisis will "reverberate across Europe", noting that former Brexit negotiator ...
Plymouth Herald3h
NHS Mounjaro warning as 90 per cent of people will be disappointed
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a ...